Analyst Ratings for Coventry Health Care (CVH)
CVH Rating Summary
CVH Price Target Summary
- Highest: $51.50 (Wells Fargo)
- Lowest: $35.00 (Barclays)
- Average: $40.68
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$40.68 (-18.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2013 | Wells Fargo | Downgrade | Market Perform (Outperform) |
51.50 (N/A) |
46.73 | 49.99 | 6.98% | Details |
| 10/5/2012 | Susquehanna | Downgrade | Neutral (Positive) |
42.00 (42.00) |
42.66 | 49.99 | 17.18% | Details |
| 9/24/2012 | Citi | Downgrade | Neutral (Buy) |
N/A (N/A) |
41.73 | 49.99 | 19.79% | Details |
| 9/11/2012 | Stifel Nicolaus | Downgrade | Hold (Buy) |
N/A (N/A) |
41.41 | 49.99 | 20.72% | Details |
| 8/30/2012 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
41.95 | 49.99 | 19.17% | Details |
| 8/27/2012 | Deutsche Bank » Updated 2/7/2013 |
Upgrade | Hold (Sell) |
46.00 (44.00) |
41.74 | 49.99 | 19.77% | Details |
| 8/21/2012 | Wedbush | Upgrade | Neutral (Underperform) |
42.00 (35.00) |
42.04 | 49.99 | 18.91% | Details |
| 8/20/2012 | Cantor Fitzgerald | Downgrade | Hold (Buy) |
42.00 (36.00) |
34.94 | 49.99 | 43.07% | Details |
| 6/20/2012 | Leerink Swann | Downgrade | Market Perform (Outperform) |
37.00 (N/A) |
34.19 | 49.99 | 46.21% | Details |
| 6/13/2012 | JPMorgan | New Coverage | Neutral (N/A) |
35.00 (N/A) |
32.70 | 49.99 | 52.87% | Details |
| 3/23/2012 | Goldman Sachs » Updated 7/11/2012 |
Upgrade | Buy (N/A) |
36.00 (35.00) |
32.21 | 49.99 | 55.2% | Details |
| 3/14/2012 | BMO Capital | Downgrade | Market Perform (N/A) |
35.00 (N/A) |
33.71 | 49.99 | 48.29% | Details |
| 2/21/2012 | Monness, Crespi, Hardt | New Coverage | Sell (N/A) |
N/A (N/A) |
32.91 | 49.99 | 51.9% | Details |
| 10/27/2011 | Bernstein | Downgrade | Market Perform (N/A) |
N/A (N/A) |
32.67 | 49.99 | 53.01% | Details |
| 8/31/2011 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
32.93 | 49.99 | 51.81% | Details |
